Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas.

Alternative splicing is part of the expression program of a wide number of genes implicated in cell growth and differentiation. Although the occurrence of inappropriate alternative splicing in tumors has started to emerge, the underlying molecular mechanisms have been, thus far, largely unexplored. We have investigated the alternative splicing pattern of the CD44 gene in specimens of nonfamilial colon adenocarcinomas at different stages of tumor progression. In the same patients, we have assessed by Northern blotting analysis the mRNA levels of different heterogeneous nuclear ribonucleoproteins and SR factors, all involved in pre-mRNA splicing and, more in general, in mRNA maturation. The results of this analysis highlight a general rule for the mode of splicing of the CD44 pre-mRNA. Moreover, we found that the mRNA levels of different SR proteins in tumor specimens are different from, and usually lower than, those detected in samples of nonpathological tissue adjacent to the tumor. Quantitative analysis demonstrates that, in tumors, the mRNA levels of ASF, SRp40, SRp55, and SRp75, when normalized to those of heterogeneous nuclear ribonucleoprotein A1, are lower than those of SRp20 and SRp30. Interestingly, this reduction is more drastic in patients showing a more altered CD44 splicing pattern and seems to be related to the propensity to develop metastases.

[1]  F. A. Coller,et al.  THE PROGNOSTIC SIGNIFICANCE OF DIRECT EXTENSION OF CARCINOMA OF THE COLON AND RECTUM , 1954, Annals of surgery.

[2]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[3]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[4]  B. Wold,et al.  Molecular cloning of cDNA for the nuclear ribonucleoprotein particle C proteins: a conserved gene family. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Riva,et al.  cDNA cloning of human hnRNP protein A1 reveals the existence of multiple mRNA isoforms. , 1988, Nucleic acids research.

[6]  Brian Seed,et al.  A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family , 1989, Cell.

[7]  C. Burd,et al.  Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1, and C2 proteins: a diversity of RNA binding proteins is generated by small peptide inserts. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[8]  I. Stamenkovic,et al.  CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.

[9]  K. Titani,et al.  Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin. , 1991, Cancer research.

[10]  M. Amiot,et al.  The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells. , 1991, The EMBO journal.

[11]  A. Gazdar,et al.  Neural cell adhesion molecule expression and messenger RNA splicing patterns in lung cancer cell lines are correlated with neuroendocrine phenotype and growth morphology. , 1991, Cancer research.

[12]  J. Bell,et al.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Riva,et al.  Human hnRNP protein A1 gene expression. Structural and functional characterization of the promoter. , 1993, Journal of molecular biology.

[14]  G. Salles,et al.  Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterization and comparison with normal activated B cells and epithelial malignancies. , 1993, Blood.

[15]  S. Riva,et al.  Phosphorylation of human hnRNP protein A1 abrogates in vitro strand annealing activity. , 1993, Nucleic acids research.

[16]  L. Castagnetta,et al.  Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. , 1993, Cancer research.

[17]  S. Galiègue‐Zouitina,et al.  Quantitative and qualitative variation of ETS-1 transcripts in hematologic malignancies. , 1993, Leukemia.

[18]  V. Chow,et al.  Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line. , 1993, Cancer letters.

[19]  Phillip A. Sharp,et al.  Split genes and RNA splicing , 1994, Cell.

[20]  A. Krainer,et al.  Mechanisms for selecting 5' splice sites in mammalian pre-mRNA splicing. , 1994, Trends in genetics : TIG.

[21]  C. Mackay,et al.  Expression and modulation of CD44 variant isoforms in humans , 1994, The Journal of cell biology.

[22]  S. Riva,et al.  New insights into the auxiliary domains of eukaryotic RNA binding proteins , 1994, FEBS letters.

[23]  W. Samowitz,et al.  Alternatively spliced adenomatous polyposis coli (APC) gene transcripts that delete exons mutated in attenuated APC. , 1995, Cancer research.

[24]  H. Ishii,et al.  A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation , 1995, Molecular and cellular biology.

[25]  M. Diaz-Meco,et al.  Identification of Heterogeneous Ribonucleoprotein A1 as a Novel Substrate for Protein Kinase C ζ (*) , 1995, The Journal of Biological Chemistry.

[26]  A. Krainer,et al.  Identification and characterization of three members of the human SR family of pre‐mRNA splicing factors. , 1995, The EMBO journal.

[27]  Y. Luqmani,et al.  Expression of 2 variant forms of fibroblast growth factor receptor 1 in human breast , 1995, International journal of cancer.

[28]  Xiang-Dong Fu,et al.  The superfamily of arginine/serine-rich splicing factors. , 1995, RNA.

[29]  W. Scheurlen,et al.  Analysis of the gap‐related domain of the neurofibromatosis type 1 (NF1) gene in childhood brain tumors , 1995, International journal of cancer.

[30]  J. Sleeman,et al.  The CD44 proteins in embryonic development and in cancer. , 1996, Current topics in microbiology and immunology.

[31]  S. Riva,et al.  The roles of heterogeneous nuclear ribonucleoproteins (hnRNP) in RNA metabolism , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[32]  P. Herrlich,et al.  Trans‐acting factors regulate the expression of CD44 splice variants. , 1996, The EMBO journal.

[33]  J. Manley,et al.  Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Kinzler,et al.  Genetic instability in colorectal cancers , 1997, Nature.

[35]  E. Schmidt,et al.  Cyclin D1 (PRAD1) alternative transcript b: full-length cDNA cloning and expression in breast cancers. , 1997, Cancer letters.

[36]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[37]  P. Herrlich,et al.  Coupling of signal transduction to alternative pre‐mRNA splicing by a composite splice regulator , 1998, The EMBO journal.